文献速递冠心病

ST段抬高型心肌梗死中的血栓抽吸:个体患者数据Meta分析:血栓切除试验者协作

Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration.
PubMed 文献 · Circulation · 2016-12-09

该个体患者数据Meta分析纳入TAPAS、TASTE和TOTAL三项大型随机对照试验,共19047例患者,其中18306例接受PCI并纳入主要分析。结果显示,常规血栓抽吸未改善临床结局;在高血栓负荷亚组中,血栓抽吸与心血管死亡减少及卒中或短暂性脑缺血发作增多相关,但交互作用P值分别为0.32和0.34。

要点

  • 常规血栓抽吸未改善ST段抬高型心肌梗死患者的临床结局。
  • 30天心血管死亡:抽吸组2.4% vs 单纯PCI组2.9%,HR 0.84(95%CI 0.70-1.01,P=0.06)。
  • 高血栓负荷亚组中抽吸与心血管死亡减少相关,但卒中或短暂性脑缺血发作增多,交互作用P值无统计学意义。

核心结论

  • ST段抬高型心肌梗死PCI中常规血栓抽吸未改善临床结局。
  • 高血栓负荷组中,心血管死亡减少和卒中或短暂性脑缺血发作增多的趋势为未来在该高危亚组中试验改进的血栓抽吸技术提供了依据。

研究设计与样本

  • 纳入大型(n≥1000)随机对照试验,比较手动血栓切除与单纯PCI治疗ST段抬高型心肌梗死患者。
  • 由各试验负责人提供个体患者数据。
  • 预设主要疗效结局为30天心血管死亡,主要安全性结局为30天卒中或短暂性脑缺血发作。
  • 共3项符合条件随机试验(TAPAS、TASTE、TOTAL)纳入19047例患者,其中18306例接受PCI并纳入主要分析。

主要发现

  • 30天心血管死亡:血栓抽吸组221/9155(2.4%)vs 单纯PCI组262/9151(2.9%),HR 0.84(95%CI 0.70-1.01,P=0.06)。
  • 30天卒中或短暂性脑缺血发作:血栓抽吸组66例(0.8%)vs 单纯PCI组46例(0.5%),OR 1.43(95%CI 0.98-2.10,P=0.06)。
  • 再发心肌梗死、支架血栓、心力衰竭或靶血管血运重建无显著差异。
  • 高血栓负荷亚组(TIMI血栓分级≥3):血栓抽吸组心血管死亡170例(2.5%)vs 单纯PCI组205例(3.1%),HR 0.80(95%CI 0.65-0.98,P=0.03);卒中或短暂性脑缺血发作55例(0.9%)vs 34例(0.5%),OR 1.56(95%CI 1.02-2.42,P=0.04);交互作用P值分别为0.32和0.34。

关键数值与推荐

  • 主要疗效结局为30天心血管死亡,主要安全性结局为30天卒中或短暂性脑缺血发作。
  • 高血栓负荷定义为TIMI血栓分级≥3。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 高血栓负荷亚组中,心血管死亡减少和卒中或短暂性脑缺血发作增多的交互作用P值分别为0.32和0.34。
  • 作者认为高血栓负荷组的趋势为未来试验改进的血栓抽吸技术提供了依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thrombus aspiration during percutaneous coronary intervention (PCI) for the treatment of ST-segment-elevation myocardial infarction (STEMI) has been widely used; however, recent trials have questioned its value and safety. In this meta-analysis, we, the trial investigators, aimed to pool the individual patient data from these trials to determine the benefits and risks of thrombus aspiration during PCI in patients with ST-segment-elevation myocardial infarction. METHODS: Included were large (n≥1000), randomized, controlled trials comparing manual thrombectomy and PCI alone in patients with ST-segment-elevation myocardial infarction. Individual patient data were provided by the leadership of each trial. The prespecified primary efficacy outcome was cardiovascular mortality within 30 days, and the primary safety outcome was stroke or transient ischemic attack within 30 days. RESULTS: The 3 eligible randomized trials (TAPAS [Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Myocardial Infarction], TASTE [Thrombus Aspiration in ST-Elevation Myocardial Infarction in Scandinavia], and TOTAL [Trial of Routine Aspiration Thrombectomy With PCI Versus PCI Alone in Patients With STEMI]) enrolled 19 047 patients, of whom 18 306 underwent PCI and were included in the primary analysis. Cardiovascular death at 30 days occurred in 221 of 9155 patients (2.4%) randomized to thrombus aspiration and 262 of 9151 (2.9%) randomized to PCI alone (hazard ratio, 0.84; 95% confidence interval, 0.70-1.01; P=0.06). Stroke or transient ischemic attack occurred in 66 (0.8%) randomized to thrombus aspiration and 46 (0.5%) randomized to PCI alone (odds ratio, 1.43; 95% confidence interval, 0.98-2.10; P=0.06). There were no significant differences in recurrent myocardial infarction, stent thrombosis, heart failure, or target vessel revascularization. In the subgroup with high thrombus burden (TIMI [Thrombolysis in Myocardial Infarction] thrombus grade ≥3), thrombus aspiration was associated with fewer cardiovascular deaths (170 [2.5%] versus 205 [3.1%]; hazard ratio, 0.80; 95% confidence interval, 0.65-0.98; P=0.03) and with more strokes or transient ischemic attacks (55 [0.9%] versus 34 [0.5%]; odds ratio, 1.56; 95% confidence interval, 1.02-2.42, P=0.04). However, the interaction P values were 0.32 and 0.34, respectively. CONCLUSIONS: Routine thrombus aspiration during PCI for ST-segment-elevation myocardial infarction did not improve clinical outcomes. In the high thrombus burden group, the trends toward reduced cardiovascular death and increased stroke or transient ischemic attack provide a rationale for future trials of improved thrombus aspiration technologies in this high-risk subgroup. CLINICAL TRIAL REGISTRATION: URLs: http://www.ClinicalTrials.gov http://www.crd.york.ac.uk/prospero/. Unique identifiers: NCT02552407 and CRD42015025936.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Jolly SS, James S, Džavík V, et al. Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration. Circulation. 2016. PMID: 27941066. doi:10.1161/CIRCULATIONAHA.116.025371

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。